Filter Results:
(155)
Show Results For
- All HBS Web
(1,287)
- People (5)
- News (155)
- Research (927)
- Events (6)
- Multimedia (12)
- Faculty Publications (758)
Show Results For
- All HBS Web
(1,287)
- People (5)
- News (155)
- Research (927)
- Events (6)
- Multimedia (12)
- Faculty Publications (758)
Sort by
- 01 Mar 2007
- News
Pharma Suits a Farm Gal
GRAHAM: From rodeo to CEO. Amylin Pharmaceuticals CEO Ginger Graham (MBA ’86) had a good year in 2006, with Amylin stock up as much as 45 percent, with Byetta and Symlin, its two innovative diabetes drugs, performing well, and with the... View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
told the Daily Mail. In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a... View Details
- 06 Mar 2023
- News
Dean Announces 2023 Alumni Achievement Award Honorees
(GMP 18, 2015) CEO and President, Vertex Pharmaceuticals Depelsha Thomas McGruder (MBA 1998) COO and Treasurer, Ford Foundation Founder, Moms of Black Boys United Raymond J. McGuire (JD/MBA 1984) Former Vice Chairman, Citigroup Antonis C.... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on drug price growth. Today,... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords: Anne Kavanagh
- 15 Dec 2024
- News
After Ozempic
these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
As it turns out, innovation doesn’t benefit everyone equally, and a new study tries to understand how that plays out in the pharmaceutical R&D process in the United States. “The numbers are striking,” says Associate Professor Joshua Schwartzstein, pointing to the fact... View Details
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the Multiple Myeloma Research... View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
self-cleaning rat cages for psychology labs. Learning that pharmaceutical companies use large quantities of rats, they negotiated a deal with him and over the next few months also executed a roll-up strategy that eventually made them the... View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created... View Details
- 01 Sep 2006
- News
HBS Student Battles ALS
people every year, is not a high priority for either the public or pharmaceutical companies. To stimulate novel treatment ideas and to raise the venture funding needed to get those ideas to market, he launched two organizations. One is... View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details
- 24 Oct 2016
- News
Health Care Pioneer Giusti Named McCance Senior Fellow at HBS
care, or engineering. Giusti currently serves as faculty cochair of the HBS-Kraft Precision Medicine Accelerator. She has more than two decades of experience in the pharmaceutical industry, having previously held senior positions at G. D.... View Details
Keywords: Susan Young
- 03 Dec 2024
- News
From One to Many
In the years after Keith Ferrazzi (MBA 1992) published Never Eat Alone, he confessed some reluctance in being labeled “the networking guy.” “But 20 years after writing that first book, and after coaching thousands of teams, I’ve finally recognized there’s a... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
headlines, the vaccine sector was a pretty sleepy space. Interest in vaccine development and production had been on the decline for decades. In the 1960s—the triumphant years after Jonas Salk discovered the first polio vaccine—there were 26 View Details
- 01 Sep 2012
- News
A Silent Workplace Crisis
pharmaceuticals, the gap between the medical and the mental health systems, and the time required to find community resources and quality home care. My previous experience as a pharmaceutical executive and management consultant seemed... View Details
- 01 Jun 2000
- News
The Right Connections
prospectuses of all public biotech firms going back twenty years. Information from 295 companies and more than 3,000 executives formed the core of their study. The results showed that top managers' ties to notable pharmaceutical companies... View Details
Keywords: Judith A. Ross